Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1979 May 5;120(9):1097–1104.

Management of the schizophrenic patient.

M V Seeman
PMCID: PMC1819293  PMID: 36218

Abstract

Schizophrenia is a continuing and relapsing disorder that begins in early adulthood and lasts indefinitely. Effective treatment, therefore, needs to be long-term and comprehensive. The physician must be able to control disabling symptoms while minimizing the side effects of neuroleptic medication. The lifetime risk remains of depression and suicide, paranoid crisis, social distress and frequent rehospitalization. It is a medical responsibility not only to look after the schizophrenic patient's health but also to coordinate social and emergency services, improve the quality of life, support the family and anticipate problems in offspring. At the time, the physician needs to consider the welfare of the community in which the schizophrenic patient lives.

Full text

PDF
1097

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackwell B. Drug therapy: patient compliance. N Engl J Med. 1973 Aug 2;289(5):249–252. doi: 10.1056/NEJM197308022890506. [DOI] [PubMed] [Google Scholar]
  2. Carpenter W. T., Jr A drug-free month for outpatient schizophrenics. Schizophr Bull. 1978;4(2):148–149. doi: 10.1093/schbul/4.2.148. [DOI] [PubMed] [Google Scholar]
  3. Crane G. E. Persistent dyskinesia. Br J Psychiatry. 1973 Apr;122(569):395–405. doi: 10.1192/bjp.122.4.395. [DOI] [PubMed] [Google Scholar]
  4. Davis J. M. Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry. 1975 Dec;132(12):1237–1245. doi: 10.1176/ajp.132.12.1237. [DOI] [PubMed] [Google Scholar]
  5. Donlon P. T., Rada R. T., Arora K. K. Depression and the reintegration phase of acute schizophrenia. Am J Psychiatry. 1976 Nov;133(11):1265–1268. doi: 10.1176/ajp.133.11.1265. [DOI] [PubMed] [Google Scholar]
  6. Donlon P. T., Rada R. T., Knight S. W. A therapeutic aftercare setting for "refractory" chronic schizophrenic patients. Am J Psychiatry. 1973 Jun;130(6):682–684. doi: 10.1176/ajp.130.6.682. [DOI] [PubMed] [Google Scholar]
  7. Engelhardt D. M., Rosen B., Freedman N., Margolis R. Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation. Arch Gen Psychiatry. 1967 Jan;16(1):98–101. doi: 10.1001/archpsyc.1967.01730190100013. [DOI] [PubMed] [Google Scholar]
  8. Gardos G., Cole J. O. The importance of dosage in antipsychotic drug administration--a review of dose-response studies. Psychopharmacologia. 1973;29(3):221–230. doi: 10.1007/BF00414036. [DOI] [PubMed] [Google Scholar]
  9. Goldberg S. C., Schooler N. R., Hogarty G. E., Roper M. Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy. Arch Gen Psychiatry. 1977 Feb;34(2):171–184. doi: 10.1001/archpsyc.1977.01770140061008. [DOI] [PubMed] [Google Scholar]
  10. Goldstein M. J., Rodnick E. H., Evans J. R., May P. R., Steinberg M. R. Drug and family therapy in the aftercare of acute schizophrenics. Arch Gen Psychiatry. 1978 Oct;35(10):1169–1177. doi: 10.1001/archpsyc.1978.01770340019001. [DOI] [PubMed] [Google Scholar]
  11. Grad J., Sainsbury P. The effects that patients have on their families in a community care and a control psychiatric service--a two year follow-up. Br J Psychiatry. 1968 Mar;114(508):265–278. doi: 10.1192/bjp.114.508.265. [DOI] [PubMed] [Google Scholar]
  12. Gunderson J. G., Mosher L. R. The cost of schizophrenia. Am J Psychiatry. 1975 Sep;132(9):901–906. doi: 10.1176/ajp.132.9.901. [DOI] [PubMed] [Google Scholar]
  13. Hansell N., Willis G. L. Outpatient treatment of schizophrenia. Am J Psychiatry. 1977 Oct;134(10):1082–1086. doi: 10.1176/ajp.134.10.1082. [DOI] [PubMed] [Google Scholar]
  14. Herz M. I., Endicott J., Spitzer R. L. Brief versus standard hospitalization: the families. Am J Psychiatry. 1976 Jul;133(7):795–801. doi: 10.1176/ajp.133.7.795. [DOI] [PubMed] [Google Scholar]
  15. Hogarty G. E., Goldberg S. C. Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates. Arch Gen Psychiatry. 1973 Jan;28(1):54–64. doi: 10.1001/archpsyc.1973.01750310038007. [DOI] [PubMed] [Google Scholar]
  16. Hogarty G. E., Goldberg S. C., Schooler N. R., Ulrich R. F. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. Arch Gen Psychiatry. 1974 Nov;31(5):603–608. doi: 10.1001/archpsyc.1974.01760170005001. [DOI] [PubMed] [Google Scholar]
  17. Jones F. H. Current methodologies for studying the development of schizophrenia: a critical review. J Nerv Ment Dis. 1973 Sep;157(3):154–178. doi: 10.1097/00005053-197309000-00002. [DOI] [PubMed] [Google Scholar]
  18. Jus A., Pineau R., Lachance R., Pelchat G., Jus K., Pires P., Villeneuve R. Epidemiology of tardive dyskinesia. Part II. Dis Nerv Syst. 1976 May;37(5):257–261. [PubMed] [Google Scholar]
  19. Kedward H. B., Eastwood M. R., Allodi F., Duckworth G. S. The evaluation of chronic psychiatric care. Can Med Assoc J. 1974 Mar 2;110(5):519–523. [PMC free article] [PubMed] [Google Scholar]
  20. Klett C. J., Caffey E., Jr Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Arch Gen Psychiatry. 1972 Apr;26(4):374–379. doi: 10.1001/archpsyc.1972.01750220084016. [DOI] [PubMed] [Google Scholar]
  21. Kobayashi R. M. Drug therapy of tardive dyskinesia. N Engl J Med. 1977 Feb 3;296(5):257–260. doi: 10.1056/NEJM197702032960506. [DOI] [PubMed] [Google Scholar]
  22. Leff J. P. Schizophrenia and sensitivity to the family environment. Schizophr Bull. 1976;2(4):566–574. doi: 10.1093/schbul/2.4.566. [DOI] [PubMed] [Google Scholar]
  23. McGlashan T. H., Carpenter W. T., Jr Postpsychotic depression in schizophrenia. Arch Gen Psychiatry. 1976 Feb;33(2):231–239. doi: 10.1001/archpsyc.1976.01770020065011. [DOI] [PubMed] [Google Scholar]
  24. Pecknold J. C., Ananth J. V., Ban T. A., Lehmann H. E. Lack of indication for use of antiparkinson medication. A follow-up study. Dis Nerv Syst. 1971 Aug;32(8):538–541. [PubMed] [Google Scholar]
  25. Reich R. Care of the chronically mentally ill--a national disgrace. Am J Psychiatry. 1973 Aug;130(8):911–912. doi: 10.1176/ajp.130.8.911. [DOI] [PubMed] [Google Scholar]
  26. Seeman M. V. Focus on co-therapy in a rehabilitation programme for advanced schizophrenia. Can Ment Health. 1976 Sep;24(3):13–14. [PubMed] [Google Scholar]
  27. Seeman M. V. Time and Schizophrenia. Psychiatry. 1976 May;39(2):189–195. doi: 10.1080/00332747.1976.11023888. [DOI] [PubMed] [Google Scholar]
  28. Sue S., McKinney H. L., Allen D. B. Predictors of the duration of therapy for clients in the community mental health system. Community Ment Health J. 1976 Winter;12(4):365–375. doi: 10.1007/BF01411075. [DOI] [PubMed] [Google Scholar]
  29. Tsuang M. T., Woolson R. F. Mortality in patients with schizophrenia, mania, depression and surgical conditions. A comparison with general population mortality. Br J Psychiatry. 1977 Feb;130:162–166. doi: 10.1192/bjp.130.2.162. [DOI] [PubMed] [Google Scholar]
  30. Van Putten T., May R. P. "Akinetic depression" in schizophrenia. Arch Gen Psychiatry. 1978 Sep;35(9):1101–1107. doi: 10.1001/archpsyc.1978.01770330075006. [DOI] [PubMed] [Google Scholar]
  31. Vaughn C. E., Leff J. P. The influence of family and social factors on the course of psychiatric illness. A comparison of schizophrenic and depressed neurotic patients. Br J Psychiatry. 1976 Aug;129:125–137. doi: 10.1192/bjp.129.2.125. [DOI] [PubMed] [Google Scholar]
  32. Wilson D. J. Ocular changes due to phenothiazine derivatives--a surgey. Trans Ophthalmol Soc U K. 1970;89:963–964. [PubMed] [Google Scholar]
  33. Wolkon G. H. Characteristics of clients and continuity of care into the community. Community Ment Health J. 1970 Jun;6(3):215–221. doi: 10.1007/BF01435919. [DOI] [PubMed] [Google Scholar]
  34. Wyatt R. J. Biochemistry and schizophrenia (part IV) the neuroleptics--their mechanism of action: a review of the biochemical literature. Psychopharmacol Bull. 1976 Jul;12(3):5–50. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES